Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701

Go back to Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 4.27 +0.04 (0.95%)
Previous Close $4.23    52 Week High $16.89 
Open $4.20    52 Week Low $7.35 
Day High $4.29    P/E N/A 
Day Low $4.17    EPS $-2.35 
Volume 407,959